NCT05638503Recruiting
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
Source: ClinicalTrials.gov · Last updated 4 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The investigators want to explore the relationship between different configurations of hypertension and the incidence of cardiovascular events by the guidelines reference range and EMINCA recommended reference range. Then the investigators want to enroll twenty research centers and 2200 hypertensions were planned to be collected and followed up in the 12th, 24th, 36th and 48th months after being enrolled in this study. Physical examination, ECG examination, laboratory examination, echocardiography and carotid ultrasound should be taken when baseline and follow-up. Echocardiographic measurement parameters were analyzed and the relationship between the echocardiographic measurement parameters and cardiovascular events and prognosis of hypertension.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2200 (estimated)
- First submitted
- 15 Nov 2022
- Start date
- 1 May 2022
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Qilu Hospital of Shandong University
- Diseases
- High blood pressure
- NCT number
- NCT05638503
What you commit to
- Study type: Observational
- Planned participants: 2200
- From 1 May 2022 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe cardiovascular and cerebrovascular diseases; heart valve disease; persistent atrial fibrillation and severe arrhythmia; previously undergone cardiovascular disease surgery;
Other illness
- Secondary hypertension caused by renal parenchymal diseases, renal vascular diseases, coarctation of aorta and endocrine system diseases;
- Abnormal liver function; abnormal renal function and diabetes;
Age
- Expected survival time due to non-cardiovascular disease\<4 years;
Other
- Pregnant or breastfeeding women;
- Patients with poor echocardiographic image quality.
Who the study is looking for
- Age 30-75 years old;
- No antihypertensive drugs were used and three blood pressure measurements were conducted on different days, with systolic blood pressure ≥ 140 mmHg (1 mmHg=0.133 kPa) and/or diastolic blood pressure ≥ 90 mmHg; or have a history of hypertension and are using antihypertensive drugs, even if the blood pressure is lower than 140/90 mmHg;
- Left ventricular ejection fraction was normal (LVEF ≥ 0.5).
- All patients agreed to participate in the experiment and signed the informed consent form.
Age in the registry: 30 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Qilu Hospital of Shandong University Coordinator of this site? Confirm its status | Jinan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.